Cutaquig Solution
Product Images NDC 68982-810

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Cutaquig (NDC 68982-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Octapharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

Image File (Img0001)
This text provides a formula for calculating the initial weekly dose of a medication, which is based on the previous intravenous immunoglobulin (IGIV) dose and the number of weeks between doses. Specifically, the initial weekly dose is determined by multiplying the previous IGIV dose in grams by 1.30. The number of weeks between doses is not provided in this text.*
FDA Label Image

Image File (Img0002)

FDA Label Image

Image File (Img0003)

FDA Label Image

Image File (Img0004)

FDA Label Image

Image File (Img0005)

FDA Label Image

Image File (Img0006)

FDA Label Image

Image File (Img0007)

FDA Label Image

Image File (Img0008)

FDA Label Image

Image File (Img0009)

FDA Label Image

Image File (Img0010)

FDA Label Image

Image File (Img0011)

Image File (Img0011)
This appears to be a data table showing the In Vitro Reduction Factor of different production steps on various types of viruses, including Non-Enveloped and Enveloped Viruses such as HIV-1, PRV, SBV, MEV, and PPV. Each production step is listed along with the corresponding reduction factor, measured in logis. The data suggests that the Ethanol fractionation and SID treatment have high reduction factors for all tested viruses, while the pH4 treatment has a relatively low reduction factor for some Enveloped Viruses like MEV and PPV.*
FDA Label Image

Image File (Img0012)

FDA Label Image

Image File (Img0013)

FDA Label Image

Image File (Img0014)

FDA Label Image

Image File (Img0015)

FDA Label Image

Image File (Img0016)

FDA Label Image

Image File (Img0017)

FDA Label Image

Image File (Img0018)

FDA Label Image

Image File (Img0019)

FDA Label Image

Image File (Img0020)

FDA Label Image

Image File (Img0021)

Image File (Img0021)
This is a description of medicine called Immune Globulin, which is used subcutaneously in humans. The medicine is called cutaquig and comes in a 10 mL pack with Sterile solution without preservative. The solution contains protein, Maltose, Polysorbate 80, and Water for injection. The medicine is manufactured by Octapharma and can be stored at +2°C to + 8°C for a maximum of 36 months. However, with shelf life, it can be stored at < +25°C for up to 9 months. The package contains an inset for dosage and administration instructions.*
FDA Label Image

Image File (Img0022)

FDA Label Image

Image File (Img0023)

Image File (Img0023)
This text appears to be a combination of codes, product names, and instructions for use. It is not clear what the overall context is, but it seems to be related to medical products and their administration. The text includes information about several different products, including Immune Globulin and Cutaquig, which are used subcutaneously and can be stored under specific conditions. The text also includes warnings about expiration dates and proper storage. Without more context, it is difficult to provide a more specific description of the text.*
FDA Label Image

Image File (Img0024)

Image File (Img0024)
This text is a description of Immune Globulin - Subcutaneous, which is a medication used for subcutaneous injection only. The medication is stored at a temperature range of +2°C to +25°C and must be discarded if not used within 9 months. The medication contains 165mg of protein, 79ng of Matose, and 80g of Polysorbate 80 in 1ml of solution. It also contains water for injection and one preservative. The medication is manufactured by Octapharma in Austria and distributed by Octapharma USA. The product is available in 24ml bottles and has an expiry date which should be followed.*
FDA Label Image

Image File (Img0025)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.